Azienda Sanitaria Locale Di Taranto

The medical center is at the forefront of research in Langerhans Cell Histiocytosis, a rare disorder characterized by the proliferation of Langerhans cells. The center's research focuses on innovative treatment protocols aimed at reducing mortality and improving patient outcomes.

• Early intervention strategies for multi-system LCH
• Prolongation and intensification of continuation therapy
• Reduction of reactivation rates and late sequelae
• Second-line treatment approaches for non-risk organ involvement

Through collaborative international efforts, the center is pioneering randomized investigations to optimize therapeutic strategies, thereby enhancing the quality of life for children and adolescents affected by this condition.